Capricor Therapeutics (CAPR) Stock Forecast & Price Target

CAPR$9.53-0.71 -6.93%
BiotechnologyValue StockGrowth Stock
Compare
Market cap$551.90MEnterprise value$591.32MRevenue (TTM)$0Market position—

Score

68
Bullish
Value
61
Quality
42
Growth
100

Capricor Therapeutics, Inc. price target

CAPR
Low$3.50
Average$12.70
High$25.00
Upside vs current price+33.3%

The average target of $12.70 is +33.3% versus the current CAPR price of $9.53.

Capricor Therapeutics, Inc. analyst ratings

RatingAnalysts
Strong buy1
Buy3
Hold6
Sell0
Strong sell0
ConsensusBuy

10 analysts cover CAPR.

Capricor Therapeutics, Inc. EPS and revenue estimates

CAPR shows the next fiscal years with at least three analysts: 2026 EPS $-1.54, 2027 EPS $-1.49. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$-1.54$92.18M
2027$-1.49$83.76M

Is Capricor Therapeutics, Inc. a buy or sell?

Of the 10 analysts covering Capricor Therapeutics, Inc., 4 rate it a buy (1 strong buy and 3 buy), 6 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The CAPR consensus label is Buy, beside 4 buy-side ratings and 0 sell-side ratings.

The average target of $12.70 implies +33.3% versus the current price of $9.53.

Those 10 ratings on CAPR are a headcount, and the label on file is Buy.

Reading the Capricor Therapeutics, Inc. forecast

The CAPR target range is wide: $3.50 at the low end, $12.70 in the middle, and $25.00 at the top.

Set next to the $9.53 CAPR quote, that average is +33.3%.

The CAPR ratings are split: 4 of 10 analysts are on the buy side, 6 are at hold, and 0 are on the sell side, and the published consensus is Buy.

Recent CAPR revisions are two-sided: 3 upgrades and 4 downgrades.

The CAPR EPS path from 2026 ($-1.54) to 2027 ($-1.49) is rising.

Only 10 analysts cover CAPR, so the average rests on a short list.

Capricor Therapeutics, Inc. forecast questions

What is the CAPR price target?

The published range for CAPR is $3.50 to $25.00, with an average of $12.70. That average is +33.3% versus the current price of $9.53.

Is Capricor Therapeutics, Inc. a buy or sell?

Of the 10 analysts covering Capricor Therapeutics, Inc., 4 rate it a buy, 6 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the CAPR headcount is 4 buy, 6 hold, and 0 sell.

What is the EPS estimate for Capricor Therapeutics, Inc.?

Analyst EPS estimates for Capricor Therapeutics, Inc.: 2026 $-1.54, 2027 $-1.49.

What is the revenue estimate for Capricor Therapeutics, Inc.?

Analyst revenue estimates for Capricor Therapeutics, Inc.: 2026 $92.18M, 2027 $83.76M.

How many analysts cover CAPR?

10 analysts cover CAPR. Their consensus on CAPR is Buy, across those 10.

CAPR price $9.53 -0.71 -6.93%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener